Praxis Precision Medicines Ownership 2024 | Who Owns Praxis Precision Medicines Now?
Institutional Ownership
0.34%
Insider Ownership
0.26%
Retail Ownership
99.40%
Institutional Holders
2.00
Praxis Precision Medicines Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | - | - | - | -131,533 | -100.00% | - | Mar 31, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -328,986 | -100.00% | - | Mar 31, 2024 |
Praxis Precision Medicines's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | - | - | - | -131,533 | -100.00% | - | Mar 31, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -328,986 | -100.00% | - | Mar 31, 2024 |
The largest Praxis Precision Medicines shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 0.00 shares of Praxis Precision Medicines (PRAX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | - | - | - | -131,533 | -100.00% | - | Mar 31, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -328,986 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Praxis Precision Medicines's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased -0.13M stocks of PRAX, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -328,986 | -100.00% | - | Mar 31, 2024 |
BAKER BROS. ADVISORS LP | - | - | - | -131,533 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Praxis Precision Medicines's biggest institutional seller is SPHERA FUNDS MANAGEMENT LTD.. The company sold -0.33M shares of PRAX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -328,986 | -100.00% | - | Mar 31, 2024 |
BAKER BROS. ADVISORS LP | - | - | - | -131,533 | -100.00% | - | Mar 31, 2024 |
Praxis Precision Medicines's largest sold out institutional shareholder by shares sold is SPHERA FUNDS MANAGEMENT LTD., sold -0.33M shares, valued at -, as of undefined.
Praxis Precision Medicines Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
CORNERCAP GROUP OF FUNDS /VA/ | 0.52% | 37,838 | 28,001 | 284.65% | Sep 30, 2022 |
Federated Hermes MDT Series | 0.15% | 360,562 | - | - | Jan 31, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.14% | 73,867 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.08% | 190,000 | - | - | Mar 28, 2024 |
PRUDENTIAL SECTOR FUNDS, INC. | 0.07% | 141,506 | - | - | Feb 29, 2024 |
BlackRock Health Sciences Trust II | 0.06% | 165,634 | - | - | Mar 31, 2024 |
TEKLA HEALTHCARE INVESTORS | 0.06% | 51,406 | - | - | Mar 31, 2024 |
TEKLA LIFE SCIENCES INVESTORS | 0.05% | 23,594 | - | - | Mar 31, 2024 |
AB CAP FUND, INC. | 0.04% | 1,357,304 | - | - | Jan 31, 2024 |
FIDELITY ADVISOR SERIES VII | 0.02% | 209,600 | - | - | Jan 31, 2024 |
FIDELITY MT VERNON STREET TRUST | 0.02% | 470,166 | - | - | Feb 29, 2024 |
Humankind Benefit Corp | 0.02% | 360 | - | - | Dec 31, 2023 |
FIDELITY SELECT PORTFOLIOS | 0.02% | 982,929 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.01% | 5,331,633 | - | - | Mar 31, 2024 |
FRANKLIN STRATEGIC SERIES | 0.01% | 103,600 | - | - | Jan 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.01% | 63,406 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,162 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.01% | 20,373 | - | - | Mar 28, 2024 |
ETFis Series Trust I | 0.01% | 8,515 | - | - | Jan 31, 2024 |
GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 22,610 | - | - | Mar 31, 2024 |
Nushares ETF Trust | 0.01% | 38,648 | - | - | Jan 31, 2024 |
JANUS INVESTMENT FUND | 0.00% | 1,173,845 | - | - | Dec 31, 2023 |
AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 16,180 | - | - | Mar 31, 2024 |
ALPS ETF Trust | 0.00% | 44,029 | - | - | Feb 29, 2024 |
FINANCIAL INVESTORS TRUST | 0.00% | 275,000 | - | - | Jan 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 684 | - | - | Mar 31, 2024 |
FIDELITY COMMONWEALTH TRUST | 0.00% | 9,700 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 88,154 | - | - | Mar 31, 2024 |
Principal Exchange-Traded Funds | 0.00% | 34,652 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 477,044 | - | - | Feb 29, 2024 |
Direxion Shares ETF Trust | 0.00% | 316,695 | - | - | Jan 31, 2024 |
Fidelity Commonwealth Trust II | 0.00% | 12,843 | - | - | Aug 31, 2023 |
Managed Portfolio Series | 0.00% | 37,838 | - | - | Jan 31, 2024 |
DRIEHAUS MUTUAL FUNDS | 0.00% | 14,093 | 14,093 | - | Mar 28, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 34,419 | - | - | Feb 29, 2024 |
BlackRock ETF Trust | 0.00% | 937 | - | - | Jan 31, 2024 |
FIDELITY COVINGTON TRUST | 0.00% | 19,055 | - | - | Jan 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 2,483 | - | - | Mar 31, 2024 |
OHIO NATIONAL FUND INC | 0.00% | 17,540 | - | - | Mar 31, 2024 |
MUTUAL FUND SERIES TRUST | 0.00% | 3,518,062 | - | - | Mar 31, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 19,216 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 21,152 | - | - | Feb 29, 2024 |
HC CAPITAL TRUST | 0.00% | 13,580 | - | - | Mar 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 54,386 | - | - | Mar 31, 2024 |
VANGUARD WORLD FUND | 0.00% | 72,696 | - | - | Feb 29, 2024 |
SCHWAB STRATEGIC TRUST | 0.00% | 156,895 | - | - | Feb 29, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,064 | - | - | Mar 31, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 590 | - | - | Mar 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 14,100 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 75,765 | - | - | Jan 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,836 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 17,051 | - | - | Mar 28, 2024 |
SPDR SERIES TRUST | 0.00% | 4,329,429 | - | - | Mar 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 6,300 | -3,300 | -34.38% | Mar 31, 2023 |
SCHWAB CAPITAL TRUST | 0.00% | 4,126 | 4,126 | - | Jan 31, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 399,501 | - | - | Mar 31, 2024 |
GOLDMAN SACHS TRUST | 0.00% | 341,825 | - | - | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 362 | - | - | Dec 31, 2023 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 170,116 | - | - | Feb 29, 2024 |
RBB FUND, INC. | 0.00% | 7,893 | 7,893 | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 15,597 | 15,597 | - | Jan 31, 2024 |
VALIC Co I | 0.00% | 17,554 | - | - | Feb 29, 2024 |
RBB FUND, INC. | 0.00% | 5,572 | - | - | Feb 29, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 6,538 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 12,568 | - | - | Jan 31, 2024 |
ProFunds | 0.00% | 604 | - | - | Mar 31, 2024 |
SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 141,700 | - | - | Dec 31, 2023 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 48,974 | - | - | Mar 31, 2024 |
PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Mar 28, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 159 | - | - | Dec 31, 2023 |
AMERICAN CENTURY ETF TRUST | 0.00% | 4,094 | 4,094 | - | Feb 29, 2024 |
TIAA-CREF FUNDS | 0.00% | 103,060 | - | - | Mar 31, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 194 | - | - | Feb 29, 2024 |
VANGUARD WELLINGTON FUND | 0.00% | 11,021 | - | - | Feb 29, 2024 |
RUSSELL INVESTMENT CO | 0.00% | 8,100 | - | - | Jan 31, 2024 |
PACE SELECT ADVISORS TRUST | 0.00% | 8,500 | - | - | Jan 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 3,440 | - | - | Jan 31, 2024 |
J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 10,889 | - | - | Jan 31, 2024 |
PROSHARES TRUST | 0.00% | 5,639 | - | - | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 20,664 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 8,782 | 8,782 | - | Jan 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 22 | - | - | Dec 31, 2023 |
PGIM ETF TRUST | 0.00% | 1,231 | - | - | Feb 29, 2024 |
EQ ADVISORS TRUST | 0.00% | 21,170 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 42,342 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 262,499 | - | - | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 5,465 | - | - | Mar 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 13,093 | - | - | Mar 31, 2024 |
SPDR INDEX SHARES FUNDS | 0.00% | 2,329 | - | - | Mar 31, 2024 |
COLUMBIA FUNDS SERIES TRUST I | 0.00% | 54,688 | - | - | Feb 29, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,097 | - | - | Feb 29, 2024 |
ETF Series Solutions | 0.00% | 189 | - | - | Jan 31, 2024 |
NORTHERN FUNDS | 0.00% | 1,136 | - | - | Mar 28, 2024 |
Franklin Alternative Strategies Funds | 0.00% | 4,216 | - | - | Feb 29, 2024 |
WILSHIRE MUTUAL FUNDS INC | 0.00% | 2,279 | - | - | Dec 31, 2023 |
Franklin Alternative Strategies Funds | 0.00% | 3,716 | - | - | Feb 29, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 135,319 | - | - | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 554 | 554 | - | Jan 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 845 | - | - | Jan 31, 2024 |
Bridge Builder Trust | 0.00% | 12,187 | - | - | Mar 31, 2024 |
Praxis Precision Medicines's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 37.84K shares, compromising 0.52% of its total assets.
Praxis Precision Medicines Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 2 | -97.37% |
30 Sep, 23 | 76 | -1.30% |
30 Jun, 23 | 77 | -13.48% |
31 Mar, 23 | 89 | -15.24% |
31 Dec, 22 | 105 | - |
30 Sep, 22 | 105 | 6.06% |
30 Jun, 22 | 99 | -3.88% |
31 Mar, 22 | 103 | 4.04% |
31 Dec, 21 | 99 | 3.13% |
30 Sep, 21 | 96 | 18.52% |
30 Jun, 21 | 81 | 19.12% |
31 Mar, 21 | 68 | -1.45% |
31 Dec, 20 | 69 | - |
As of 31 Dec 23, 2 institutions are holding Praxis Precision Medicines's shares, representing a decrease of -97.37% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 460,519 | -99.60% |
30 Sep, 23 | 114,399,484 | -2.21% |
30 Jun, 23 | 116,984,506 | 119.92% |
31 Mar, 23 | 53,194,904 | 16.78% |
31 Dec, 22 | 45,551,342 | 8.28% |
30 Sep, 22 | 42,067,277 | -2.43% |
30 Jun, 22 | 43,114,530 | -5.06% |
31 Mar, 22 | 45,410,123 | 3.68% |
31 Dec, 21 | 43,796,533 | 2.23% |
30 Sep, 21 | 42,839,658 | 4.04% |
30 Jun, 21 | 41,175,054 | 12.42% |
31 Mar, 21 | 36,626,237 | 1.17% |
31 Dec, 20 | 36,202,782 | - |
Praxis Precision Medicines (PRAX) has 460.52K shares outstanding as of 31 Dec 23, down -99.60% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 0.34% | 0.00% |
30 Sep, 23 | 164.04% | 0.34% |
30 Jun, 23 | 220.30% | 2.20% |
31 Mar, 23 | 100.17% | 1.03% |
31 Dec, 22 | 98.82% | 1.17% |
30 Sep, 22 | 91.90% | 1.03% |
30 Jun, 22 | 94.67% | 0.95% |
31 Mar, 22 | 99.90% | 1.05% |
31 Dec, 21 | 97.40% | 1.06% |
30 Sep, 21 | 95.81% | 0.98% |
30 Jun, 21 | 99.05% | 1.09% |
31 Mar, 21 | 95.21% | 1.06% |
31 Dec, 20 | 94.60% | - |
As of 31 Dec 23, Praxis Precision Medicines is held by 0.34% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 33 | -13.16% |
30 Jun, 23 | 38 | -25.49% |
31 Mar, 23 | 51 | 8.51% |
31 Dec, 22 | 47 | -9.62% |
30 Sep, 22 | 52 | -17.46% |
30 Jun, 22 | 63 | 18.87% |
31 Mar, 22 | 53 | -13.11% |
31 Dec, 21 | 61 | 3.39% |
30 Sep, 21 | 59 | -7.81% |
30 Jun, 21 | 64 | 77.78% |
31 Mar, 21 | 36 | -47.83% |
31 Dec, 20 | 69 | - |
- institutional shareholders have increased their position in PRAX stock as of 31 Dec 23 compared to 33 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | 2 | -90.00% |
30 Sep, 23 | 20 | -20.00% |
30 Jun, 23 | 25 | 25.00% |
31 Mar, 23 | 20 | -47.37% |
31 Dec, 22 | 38 | 18.75% |
30 Sep, 22 | 32 | 60.00% |
30 Jun, 22 | 20 | -16.67% |
31 Mar, 22 | 24 | 60.00% |
31 Dec, 21 | 15 | -16.67% |
30 Sep, 21 | 18 | 80.00% |
30 Jun, 21 | 10 | -33.33% |
31 Mar, 21 | 15 | - |
31 Dec, 20 | - | - |
2 institutional shareholders have reduced their position in PRAX stock as of 31 Dec 23 compared to 20 in the previous quarter (a -90.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 2 | -97.37% | 460,519 | -99.60% | 0.34% | 0.00% | - | -100.00% | 2 | -90.00% |
30 Sep, 23 | 76 | -1.30% | 114,399,484 | -2.21% | 164.04% | 0.34% | 33 | -13.16% | 20 | -20.00% |
30 Jun, 23 | 77 | -13.48% | 116,984,506 | 119.92% | 220.30% | 2.20% | 38 | -25.49% | 25 | 25.00% |
31 Mar, 23 | 89 | -15.24% | 53,194,904 | 16.78% | 100.17% | 1.03% | 51 | 8.51% | 20 | -47.37% |
31 Dec, 22 | 105 | - | 45,551,342 | 8.28% | 98.82% | 1.17% | 47 | -9.62% | 38 | 18.75% |
30 Sep, 22 | 105 | 6.06% | 42,067,277 | -2.43% | 91.90% | 1.03% | 52 | -17.46% | 32 | 60.00% |
30 Jun, 22 | 99 | -3.88% | 43,114,530 | -5.06% | 94.67% | 0.95% | 63 | 18.87% | 20 | -16.67% |
31 Mar, 22 | 103 | 4.04% | 45,410,123 | 3.68% | 99.90% | 1.05% | 53 | -13.11% | 24 | 60.00% |
31 Dec, 21 | 99 | 3.13% | 43,796,533 | 2.23% | 97.40% | 1.06% | 61 | 3.39% | 15 | -16.67% |
30 Sep, 21 | 96 | 18.52% | 42,839,658 | 4.04% | 95.81% | 0.98% | 59 | -7.81% | 18 | 80.00% |
30 Jun, 21 | 81 | 19.12% | 41,175,054 | 12.42% | 99.05% | 1.09% | 64 | 77.78% | 10 | -33.33% |
31 Mar, 21 | 68 | -1.45% | 36,626,237 | 1.17% | 95.21% | 1.06% | 36 | -47.83% | 15 | - |
31 Dec, 20 | 69 | - | 36,202,782 | - | 94.60% | - | 69 | - | - | - |
Praxis Precision Medicines Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Praxis Precision Medicines's stock was made by Mastrocola Lauren on Feb 14 2024, selling 48 shares at $44.65 per share (valued at $2.14K).
Praxis Precision Medicines Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 7 | - | - |
Q2 2024 | 8 | - | - |
Q1 2024 | 4 | 7 | 57.14% |
Q4 2023 | 1 | - | - |
Q2 2023 | 10 | - | - |
Q1 2023 | 14 | 8 | 175.00% |
Q4 2022 | 3 | - | - |
Q2 2022 | 25 | - | - |
Q1 2022 | 12 | 4 | 300.00% |
Q4 2021 | - | 3 | - |
Q3 2021 | 2 | 8 | 25.00% |
Q2 2021 | 9 | 1 | 900.00% |
Q1 2021 | 11 | 1 | 1100.00% |
Q4 2020 | 19 | 52 | 36.54% |
Q4 2019 | - | 1 | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Praxis Precision Medicines's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | 1 | - | - |
Q2 2023 | 1 | - | - |
Q1 2023 | 5 | - | - |
Q4 2022 | - | - | - |
Q2 2022 | 5 | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | 3 | - |
Q3 2021 | 2 | 8 | 25.00% |
Q2 2021 | - | - | - |
Q1 2021 | - | - | - |
Q4 2020 | 2 | - | - |
Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Praxis Precision Medicines's stocks.
Praxis Precision Medicines Peer Ownership
Ticker | Company |
---|---|
PMVP | PMV Pharmaceuticals, Inc. |
CGEM | Cullinan Oncology, Inc. |
DYN | Dyne Therapeutics, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
MLYS | Mineralys Therapeutics, Inc. |
EWTX | Edgewise Therapeutics, Inc. |
STOK | Stoke Therapeutics, Inc. |
ANTX | AN2 Therapeutics, Inc. |
HCWB | HCW Biologics Inc. |
CRNX | Crinetics Pharmaceuticals, Inc. |
PHVS | Pharvaris N.V. |
IMRX | Immuneering Corporation |
PEPG | PepGen Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
MOLN | Molecular Partners AG |
ELVN | Enliven Therapeutics, Inc. |
ELYM | Eliem Therapeutics, Inc. |
PRAX Ownership FAQ
Who Owns Praxis Precision Medicines?
Praxis Precision Medicines is owned by institutional shareholders (0.34%), insiders (0.26%), and public (99.40%). The largest institutional shareholder of Praxis Precision Medicines is BAKER BROS. ADVISORS LP (0% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.52% of total shares).
Who are the major institutional shareholders of Praxis Precision Medicines?
Praxis Precision Medicines's major institutional shareholders are BAKER BROS. ADVISORS LP, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 0% of the company's share outstanding.
How many Praxis Precision Medicines shareholders are there?
As of Dec 2023, there are 2 institutional shareholders of Praxis Precision Medicines.
What percentage of Praxis Precision Medicines is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP owns 0 shares of Praxis Precision Medicines, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Praxis Precision Medicines is owned by SPHERA FUNDS MANAGEMENT LTD?
As of Mar 2024, SPHERA FUNDS MANAGEMENT LTD holds 0 shares of Praxis Precision Medicines (PRAX), compromising 0% of the company, valued at $0.